Buscar
Mostrando ítems 71-75 de 75
A greater virulent HIV-1 subtype B variant has circulated in The Netherlands since the 1990’s
(AIDS Reviews, 2022)
Despite being COVID-19 the global focus of attention nowadays, other pandemics caused by RNA viruses are ongoing. This is the case for AIDS. Roughly, 38 million people are, at present, living with HIV-1 infection worldwide ...
Oral antivirals for the prevention and treatment of SARS-CoV-2 infection
(AIDS Reviews, 2022)
Vaccines and antivirals are the classical weapons deployed to contain, prevent, and treat life-threatening
viral illnesses. Specifically, for SARS-CoV-2 infection, vaccines protect against severe COVID-19 disease
manifestations ...
The unexpected high prevalence of HBV subgenotype D4 in patients with chronic hepatitis B in Galicia, a northwestern Spanish region, reflects strong links with Latin America
(Journal of Clinical Virology, 2022)
Background: Hepatitis B virus (HBV) comprises 9 genotypes and multiple subgenotypes that depict differences in geographic distribution, clinical outcome and response to antiviral therapy. However, the molecular epidemiology ...
Providing Spiritual Care to In-Hospital Patients During COVID-19: A Preliminary European Fact-Finding Study
(Journal of Religion & Health, 2022)
Historically, there has be a close relationship between the nursing services and spiritual care provision to patients, arising due to the evolvement of many hospitals and nursing programmes from faith-based institutions ...
Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
(Elsevier B.V., 2022)
Viral hepatitis is among the top four causes of mortality globally, causing 1.4 million deaths each year, exceeding tuberculosis, malaria and human immunodeficiency virus. Hepatitis B and C are responsible for 90% of ...